PNAS, 2012 · DOI: 10.1073/pnas.1113953109 · Published: March 27, 2012
The study investigates the role of ephrinB3, a protein found in myelin, in limiting axon regeneration after central nervous system (CNS) injuries. The research uses mice lacking a functional ephrinB3 gene to examine axon regeneration following optic nerve crush and spinal cord injury. The experiments showed that without ephrinB3, there was a significant increase in axon regeneration after both optic nerve and spinal cord injuries. This suggests that ephrinB3 contributes to the failure of axons to regrow after CNS trauma. The findings indicate that targeting ephrinB3 could be a therapeutic strategy to promote axon regeneration and improve recovery after CNS injuries. However, the study also notes complexities, such as altered gait and spasms in ephrinB3-deficient mice, indicating a need for careful consideration in therapeutic development.
EphrinB3 is a potential therapeutic target for promoting axonal regeneration after CNS injuries.
Combined interruption of ephrinB3 and NgR1 ligands may be more effective in promoting regeneration.
Considering developmental abnormalities associated with ephrinB3 deficiency is important in developing therapies.